Xiaowei Hu

660 total citations · 1 hit paper
19 papers, 434 citations indexed

About

Xiaowei Hu is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaowei Hu has authored 19 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Neurology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaowei Hu's work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Neurological Disease Mechanisms and Treatments (3 papers) and MicroRNA in disease regulation (3 papers). Xiaowei Hu is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Neurological Disease Mechanisms and Treatments (3 papers) and MicroRNA in disease regulation (3 papers). Xiaowei Hu collaborates with scholars based in China, Switzerland and Australia. Xiaowei Hu's co-authors include Lisheng Chu, Yan Fang, Li Lin, Shihui Mao, Weifeng Jiang, Yan Yang, Baojian Yu, Lin Li, Jianping Zhang and Yan Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and BioMed Research International.

In The Last Decade

Xiaowei Hu

18 papers receiving 431 citations

Hit Papers

Quercetin improves cerebral ischemia/reperfusion injury b... 2023 2026 2024 2025 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Quercetin improves cerebral ischemia/reperfusion injury by promoting microglia/macrophages M2 polarization via regulating PI3K/Akt/NF-κB signaling pathway
    2023 122 citations Lin Li, Weifeng Jiang et al. Biomedicine & Pharmacotherapy profile →

Peers

Xiaowei Hu
Yan-ting Gu China
Shuai Hou China
Seo‐Yeon Lee South Korea
Jin Zhu China
Zhiping Dong China
Yuyou Huang China
Derek Barthels United States
Yonglin Zhao China
Jingru Zhao China
Yan-ting Gu China
Xiaowei Hu
Citations per year, relative to Xiaowei Hu Xiaowei Hu (= 1×) peers Yan-ting Gu

Countries citing papers authored by Xiaowei Hu

Since Specialization
Citations

This map shows the geographic impact of Xiaowei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Hu more than expected).

Fields of papers citing papers by Xiaowei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Hu. The network helps show where Xiaowei Hu may publish in the future.

Co-authorship network of co-authors of Xiaowei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Hu. A scholar is included among the top collaborators of Xiaowei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Hu. Xiaowei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Yuzhu, Li Guo, Peng Nie, et al.. (2025). Targeting BACH1 by HPPE inhibits the Wnt/β-catenin pathway and malignant phenotype in glioblastoma cells. APOPTOSIS. 30(11-12). 2848–2867.
2.
Li, Lin, Weifeng Jiang, Shihui Mao, et al.. (2025). Artemisinin alleviates ischemic stroke injury and promotes neurogenesis through PPARγ-mediated M2 polarization of microglia. Phytomedicine. 142. 156769–156769. 2 indexed citations
3.
Mao, Shihui, Xiaowei Hu, Li Lin, et al.. (2024). Exosomal miR-486 derived from bone marrow mesenchymal stem cells promotes angiogenesis following cerebral ischemic injury by regulating the PTEN/Akt pathway. Scientific Reports. 14(1). 18086–18086. 13 indexed citations
4.
Wang, Tianyue, et al.. (2023). Exploring the mechanism of luteolin by regulating microglia polarization based on network pharmacology and in vitro experiments. Scientific Reports. 13(1). 13767–13767. 20 indexed citations
5.
Jiang, Weifeng, et al.. (2023). MiR‐199a‐5p enhances neuronal differentiation of neural stem cells and promotes neurogenesis by targeting Cav‐1 after cerebral ischemia. CNS Neuroscience & Therapeutics. 29(12). 3967–3979. 13 indexed citations
6.
Li, Lin, Weifeng Jiang, Baojian Yu, et al.. (2023). Quercetin improves cerebral ischemia/reperfusion injury by promoting microglia/macrophages M2 polarization via regulating PI3K/Akt/NF-κB signaling pathway. Biomedicine & Pharmacotherapy. 168. 115653–115653. 122 indexed citations breakdown →
7.
Hu, Xiaowei, Yu Zhou, Johanna M. Ospel, et al.. (2022). Intracranial hemorrhage in large vessel occlusion patients receiving endovascular thrombectomy with or without intravenous alteplase: a secondary analysis of the DIRECT-MT trial. Journal of NeuroInterventional Surgery. 15(10). 977–982. 5 indexed citations
8.
Hu, Hui, Xiaowei Hu, Yan Fang, et al.. (2022). Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Promote Angiogenesis in Ischemic Stroke Mice via Upregulation of MiR-21-5p. Biomolecules. 12(7). 883–883. 72 indexed citations
9.
Hu, Xiaowei, et al.. (2022). Utilization of quantitative electroencephalogram in China: an online questionnaire survey. SHILAP Revista de lepidopterología. 4(1). 2 indexed citations
10.
Lin, Li, Yan Fang, Yan Yang, et al.. (2021). Astragaloside IV promotes microglia/macrophages M2 polarization and enhances neurogenesis and angiogenesis through PPARγ pathway after cerebral ischemia/reperfusion injury in rats. International Immunopharmacology. 92. 107335–107335. 106 indexed citations
11.
Lu, Jiajie, Xiaowei Hu, Yiren Qin, et al.. (2021). The Efficacy of Percutaneous Patent Foramen Ovale Closure on Migraine: a Meta‐Analysis of Randomized Controlled Trials and Observational Studies. BioMed Research International. 2021(1). 6643266–6643266. 12 indexed citations
12.
Lu, Jiajie, Quanquan Zhang, Xiaoning Guo, et al.. (2021). Calcitonin Gene–Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison. Frontiers in Pharmacology. 12. 631204–631204. 17 indexed citations
13.
Wang, Dongxing, et al.. (2020). Serum Neuropeptide Y Level is Associated with Post-Ischemic Stroke Epilepsy. Journal of Stroke and Cerebrovascular Diseases. 30(2). 105475–105475. 9 indexed citations
14.
Wang, Dapeng, Lulu Zhang, Xiaowei Hu, et al.. (2020). Intravenous Thrombolysis Benefits Mild Stroke Patients With Large-Artery Atherosclerosis but No Tandem Steno-Occlusion. Frontiers in Neurology. 11. 340–340. 9 indexed citations
15.
16.
17.
Zhang, Lulu, Xiaowei Hu, Juehua Zhu, et al.. (2017). Adequate Platelet Function Inhibition Confirmed by Two Inductive Agents Predicts Lower Recurrence of Ischemic Stroke/Transient Ischemic Attack. BioMed Research International. 2017. 1–5. 4 indexed citations
18.
Yang, Yuping, Tao Xue, Juehua Zhu, et al.. (2017). Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction. Clinical Neurology and Neurosurgery. 160. 40–45. 8 indexed citations
19.
Xu, Lei, Xiaowei Hu, Shuhua Zhang, et al.. (2016). Intensified Antiplatelet Treatment Reduces Major Cardiac Events in Patients with Clopidogrel Low Response. Chinese Medical Journal. 129(8). 984–991. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan-ting Gu Breakdown of academic impact, for papers by Shuai Hou Breakdown of academic impact, for papers by Seo‐Yeon Lee Breakdown of academic impact, for papers by Jin Zhu Breakdown of academic impact, for papers by Zhiping Dong Breakdown of academic impact, for papers by Yuyou Huang Breakdown of academic impact, for papers by Derek Barthels Breakdown of academic impact, for papers by Yonglin Zhao Breakdown of academic impact, for papers by Jingru Zhao
Rankless by CCL
2026